McKinsey's View That Pharma Megamergers Work Is Short Sighted

Feb 24 2014, 7:16am CST | by

In the article, “Why pharma megamergers work”, McKinsey authors Myoung Cha and Theresa Lorriman argue that: “Unlike deals in many industries, big mergers and acquisitions among pharmaceutical companies generally have resulted in positive returns for shareholders.” They believe that megamergers have created shareholder value and that consolidation deals have generated greater economic growth.

Interestingly, they use the three megamergers that Pfizer engaged in over the past 15 years (Warner-Lambert, Pharmacia and then Wyeth) to help make their points. There is no doubt that from an immediate business impact, these deals can make a lot of sense. Benefits include a broader portfolio of products, opportunities to cut costs by eliminating duplication and overlap, and increased availability of working capital. Indeed, it is not unusual for a company’s stock price to increase when such an acquisition is announced.

However, a pharmaceutical company, by the nature of its business, requires a long-term vision. Because the drug discovery and development process can take 12- 15 years, oftentimes the impact of a major event isn’t felt for a number of years. The integration of two organizations is incredibly difficult. This is particularly true in an R&D organization. New organization structures need to be developed; new processes must be implemented; decisions need to be made as to which programs should progress, which should be eliminated; new leaders need to be selected, others moved aside; and, in order to generate the synergies promised to Wall Street, research sites need to be shuttered.

The disruption that the integration process causes is immeasurable. Winners and losers are created as a result of the leader selection process. Scars form as different research teams battle over which projects are superior to others. The angst even extends to one’s home life as people worry if their site will be closed and that they’ll be unemployed or, at best, be asked to uproot their families halfway across the country to a new research location. In such a situation, rumors are rife and speculation rampant. Focus that should be on science inevitably get diverted to one’s personal situation. This isn’t something that lasts just a few weeks. Often the integration process can take as much as a year.

The impact of these changes are not immediate. Rather, they take some years to become apparent. The Pfizer pipeline of experimental medicines, as published on its website, is about 60% of its peak about a decade ago, despite these acquisitions. Clearly, a company’s success isn’t assured by numbers, but one’s chances are enhanced by more R&D opportunities. I would argue these mergers have taken a toll on the R&D organization that wasn’t anticipated a decade ago.

One wonders why McKinsey chose to publish such an article. Perhaps the answer can be found in the article’s closing line. “Given the proven track record of consolidation deals generating economic profit, we would not be surprised to see them come back in vogue.” McKinsey would love for this to happen. They are usually in the middle of facilitating these mergers, generating their own economic benefits.

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

$7 bn Mars rocket set for 2018 debut: NASA
Washington, Aug 28 (IANS) The National Aeronautics and Space Administration (NASA) has announced to launch its $7 billion Space Launch System (SLS) - the heavy-lift, exploration class rocket under development to take humans beyond earth and eventually to Mars - by November 2018.
 
 
Miami to have 1,000 feet observation tower
Miami, Aug 28 (IANS/EFE) The voters of Miami in the US have approved a proposal by a real estate promoter to build a 1,000 feet high observation tower here.
 
 
Ebola epidemic to get worse: health official
London, Aug 28 (IANS) The Ebola outbreak in West Africa will get worse before it gets better, said a top public health official, the BBC reported Thursday.
 
 
12 Indian firms among Forbes Asia's Fabulous 50
Washington, Aug 28 (IANS) A dozen Indian firms figure in this year's Forbes Asia's Fabulous 50 list of the region's best big publicly traded companies with HDFC Bank making the list more times than any other company.
 
 
 

Latest from the Network

Bangladesh still winless after rain wrecks T20
Basseterre (St. Kitts), Aug 28 (IANS/CMC) Only 28 deliveries were possible as rain wrecked the one-off Twenty20 International between the West Indies and Bangladesh here. Bangladesh were cruising at 31 without loss...
Read more on Sport Balla
 
$7 bn Mars rocket set for 2018 debut: NASA
Washington, Aug 28 (IANS) The National Aeronautics and Space Administration (NASA) has announced to launch its $7 billion Space Launch System (SLS) - the heavy-lift, exploration class rocket under development to take...
Read more on Apple Balla
 
Miami to have 1,000 feet observation tower
Miami, Aug 28 (IANS/EFE) The voters of Miami in the US have approved a proposal by a real estate promoter to build a 1,000 feet high observation tower here. Sixty-nine percent of the voters approved the plans of...
Read more on Business Balla
 
Ebola epidemic to get worse: health official
London, Aug 28 (IANS) The Ebola outbreak in West Africa will get worse before it gets better, said a top public health official, the BBC reported Thursday. Tom Frieden, director of the US-based Centres for Disease...
Read more on Business Balla
 
12 Indian firms among Forbes Asia's Fabulous 50
Washington, Aug 28 (IANS) A dozen Indian firms figure in this year's Forbes Asia's Fabulous 50 list of the region's best big publicly traded companies with HDFC Bank making the list more times than any other company....
Read more on Business Balla
 
First gay sailor of Chilean navy
London, Aug 28 (IANS) A sailor in Chile has become the first serving member of the Chilean armed forces to announce he is gay, the BBC reported Thursday. Mauricio Ruiz, 24, said his decision had "not been easy", but...
Read more on Politics Balla
 
Pakistani cleric ends talks with government
Islamabad, Aug 28 (IANS) Pakistan Awami Tehreek leader Tahir-ul-Qadri Thursday announced he was ending dialogue with the government as his demands were not accepted. Qadri, whose supporters have staged an anti-...
Read more on Politics Balla
 
Verona sign Brazilian midfielder Campanharo
Rio de Janeiro, Aug 28 (IANS) Hellas Verona have signed midfielder Gustavo Campanharo on a season-long loan from Brazilian club Bragantino. In a statement on their official website, the Italian Serie A outfit said the...
Read more on Sport Balla
 
Huntington-Whiteley loves making creative decision
London, Aug 28 (IANS) Supermodel Rosie Huntington-Whiteley has enjoyed indulging her creative tendencies since leaving Victoria's Secret. Huntington-Whiteley has revealed that working with British high street store...
Read more on Celebrity Balla
 
Holmes offers $1,000 reward for return of Suri's pet
Los Angeles, Aug 28 (IANS) Actress Katie Holmes has reportedly offered a $1000 reward for the safe return of her daughter's pet dog following its disappearance. Suri's new new Chihuahua, Honey, went missing Sunday....
Read more on Celebrity Balla